Glycomics in Canada receives crucial funding boost to further life-saving research and biotechnology development.
Category: Press Release
GlycoNet startup, ABOzymes, completes seed financing round to fund development of technology to enable universal organ transplants and blood transfusions
Glycomics is an integral part of ABOzymes’ life-saving research and technology development.
GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen
This collaboration combines Alectos’ expertise in small-molecule therapeutics with Biogen’s development capabilities in movement disorders.
GlycoNet and partners invest $7.7 million in Canadian health innovation
This investment will support state-of-the-art health research for Canada’s leading diseases, including cancer, diabetes, dementia, muscular dystrophy and universal donor blood.
GlycoNet joins national industry association to drive economic growth in the biotechnology sector
As a member of BIOTECanada’s network, GlycoNet aims to mobilize glycomics research into tangible and sustainable innovation for Canadians.
GlycoNet Investigator develops new chemistry to facilitate drug development and manufacturing
The collaborative project is partnered with CQDM, Simon Fraser University, Amgen, Merck, and Servier.
GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research
Genetic disease research has benefitted substantially from the study of glycomics, which relates to the functions of glycans, or sugar, in biological systems
Canadian Glycomics Network launches Call for Proposals for glycomics projects to address fundamental health challenges in Canada
The Network will commit $1.8 million in glycomics to support made-in-Canada health innovations and build a sustainable national bioeconomy
GlycoNet-affiliated start-up 48Hour Discovery and Merck initiate drug discovery project
Project funded through CQDM Quantum Leap program with support from Merck and GlycoNet will exploit new drug development platform
New glycomics research investments from GlycoNet to facilitate a resilient recovery for Canada
$1.3 million in funding to support new sugar research to tackle unmet needs in national healthcare
English 
French